ArticleJournal of lipid research2020

ANGPTL3, PCSK9, and statin therapy drive remarkable reductions in hyperlipidemia and atherosclerosis in a mouse model.

Eva Hurt-CamejoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.